Report on the risk assessment of 2-(methylamino)-1-(3-methylphenyl)propan-1-one (3-methylmethcathinone, 3-MMC) in accordance with Article 5c of Regulation (EC) No 1920/2006 (as amended) 17. March 2022, section EUDA news
9. June 2026 New health risks for Europeans in a fast-moving drug market People who use drugs in Europe are facing new health risks as drug markets evolve rapidly and become more complex. This...
